Clinical trial
Gemcitabine + Carboplatin in Breast Cancer
NCT00450762 · Ludwig-Maximilians - University of Munich, Other · Completed
Key facts
| NCT number | NCT00450762 |
|---|---|
| Title | Gemcitabine + Carboplatin in Breast Cancer |
| Official title | Gemcitabine Plus Carboplatin in Patients With Pretreated Metastatic Breast Cancer |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine, carboplatin |
| Start date | Mar 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Mar 22, 2007 |
| Last update posted | Mar 22, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: